1 |
Antibiotic use in the community: what factors influence primary care physicians to prescribe antibiotics in Delhi, India? |
|
| |
Kotwani A, Wattal C, Katewa S, Joshi PC, Holloway K |
| Fam Pract. 2010 Jul;():. |
|
|
|
2 |
Commentary: will generic drug stores improve access to essential medicines for the poor in India? |
|
| |
Kotwani A |
| J Public Health Policy. 2010 Jul;31(2):178-84. |
|
|
|
3 |
Methodology for surveillance of antimicrobials use among out-patients in Delhi. |
|
| |
Kotwani A, Holloway K, Chaudhury RR |
| Indian J Med Res. 2009 May;129(5):555-60. |
|
|
|
4 |
Insights for policymakers from a medicine price survey in Rajasthan. |
|
| |
Kotwani A, Gurbani N, Sharma S, Chaudhury RR |
| Indian J Med Res. 2009 Apr;129(4):451-4. |
|
|
|
5 |
Availability, price and affordability of asthma medicines in five Indian states. |
|
| |
Kotwani A |
| Int J Tuberc Lung Dis. 2009 May;13(5):574-9. |
|
|
|
6 |
Tackling the health-poverty nexus: primary care medicine and intersectoral health action. |
|
| |
Kotwani N, Danis M |
| J Gen Intern Med. 2007 Nov;22(11):1632-3. |
|
|
|
7 |
Prices & availability of common medicines at six sites in India using a standard methodology. |
|
| |
Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R |
| Indian J Med Res. 2007 May;125(5):645-54. |
|
|
|
8 |
Treatment of neonatal candidiasis with liposomal amphotericin B(L-AMP-LRC-1): phase II study. |
|
| |
Kotwani RN, Bodhe PV, Kirodian BG, Mehta KP, Ali US, Kshirsagar NA |
| Indian Pediatr. 2003 Jun;40(6):545-50. |
|
|
|
9 |
Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. |
|
| |
Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK |
| J Assoc Physicians India. 2002 May;50(5):662-70. |
|
|
|
10 |
A comparative study of plasma concentrations of liposomal amphotericin B (L-AMP-LRC-1) in adults, children and neonates. |
|
| |
Kotwani RN, Gokhale PC, Bodhe PV, Kirodian BG, Kshirsagar NA, Pandya SK |
| Int J Pharm. 2002 May;238(1-2):11-5. |
|
|
|
|
|
| Next >> |